 | | PRD_900122 | | Name: | Sialyl-Lewis X antigen, alpha anomer | | Formula: | C31 H52 N2 O23 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900123 | | Name: | Lewis B antigen, beta anomer | | Formula: | C26 H45 N O19 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900124 | | Name: | Lewis Y antigen, alpha anomer | | Formula: | C26 H45 N O19 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900125 | | Name: | H type 2 antigen, alpha anomer | | Formula: | C20 H35 N O15 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900126 | | Name: | Blood group A Lewis B antigen, beta anomer | | Formula: | C34 H58 N2 O24 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900127 | | Name: | Blood group A Lewis Y antigen, beta anomer | | Formula: | C34 H58 N2 O24 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900128 | | Name: | Blood group A Lewis Y antigen, alpha anomer | | Formula: | C34 H58 N2 O24 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_002374 | | Name: | cyclic trypsin inhibitor | | Formula: | C66 H106 N18 O18 | | Definition date: | 2020-07-01 | | Last modified: | 2020-07-02 |
|
 | | PRD_002375 | | Name: | cyclic trypsin inhibitor | | Formula: | C69 H109 N21 O18 | | Definition date: | 2020-07-01 | | Last modified: | 2020-07-02 |
|
 | | PRD_002127 | | Name: | N-[4-(hydroxymethyl)benzoyl]-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | | Formula: | C38 H54 N7 O11 P | | Definition date: | 2014-12-03 | | Last modified: | 2020-06-27 |
|
 | | PRD_002393 | | Name: | UAW247 | | Formula: | C24 H27 N3 O5 | | Definition date: | 2020-06-17 | | Last modified: | 2020-06-17 |
|
 | | PRD_002385 | | Name: | Papain-like protease peptide inhibitor VIR250 | | Formula: | C23 H32 N6 O6 S | | Definition date: | 2020-05-20 | | Last modified: | 2020-05-20 |
|
 | | PRD_001136 | | Name: | SUGAR (6-MER) | | Formula: | C57 H82 O26 | | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | | Definition date: | 2013-07-26 | | Last modified: | 2020-04-04 |
|
 | | PRD_002326 | | Name: | Phosphinic inhibitor DG014 | | Formula: | C62 H91 N9 O18 P | | Definition date: | 2019-12-18 | | Last modified: | 2019-12-18 |
|
 | | PRD_002357 | | Name: | SHV-WFP-SER-PRO-YCP-ALA-MP8 Acyldepsipeptide | | Formula: | C39 H54 F2 N6 O8 | | Definition date: | 2019-11-06 | | Last modified: | 2019-11-06 |
|
 | | PRD_002359 | | Name: | OO1-WFP-SER-PRO-YCP-ALA-MP8 ureadepsipeptide | | Formula: | C40 H49 F2 N7 O8 | | Definition date: | 2019-11-06 | | Last modified: | 2019-11-06 |
|
 | | PRD_002368 | | Name: | cyclo-Mle-Phe-Mle-D-Phe. D-Phe analogue of pseudoxylallemycin A | | Formula: | C32 H44 N4 O4 | | Definition date: | 2019-10-02 | | Last modified: | 2019-10-02 |
|
 | | PRD_002333 | | Name: | Pseudoxylallemycin A | | Formula: | C32 H44 N4 O4 | | Definition date: | 2019-09-11 | | Last modified: | 2019-09-11 |
|
 | | PRD_002334 | | Name: | Linear tetrapeptide related to pseudoxylallemycin A | | Formula: | C32 H46 N4 O5 | | Definition date: | 2019-09-11 | | Last modified: | 2019-09-11 |
|
 | | PRD_002335 | | Name: | Linear precursor of pseudoxylallemycin A | | Formula: | C32 H46 N4 O5 | | Description: | Mle-Phe-Mle-Phe. Linear precursor of pseudoxylallemycin A. The peptide is linear, unlike Mle-Phe-Mle-Phe Pseudoxylallemycin A that is cyclic. | | Definition date: | 2019-09-11 | | Last modified: | 2019-09-11 |
|
 | | PRD_002355 | | Name: | Microcin C | | Formula: | C38 H63 N17 O17 P S | | Definition date: | 2019-07-10 | | Last modified: | 2019-07-10 |
|
 | | PRD_002306 | | Name: | (2S,5R,8S,11S,14R,17S,20S,22R,23S)-5-[(2E)-but-2-en-1-yl]-23-hydroxy-8-({1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-1H-indol-3-yl}methyl)-14-[(4-hydroxy-3-nitrophenyl)methyl]-10,17,19,22-tetramethyl-2,11-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone | | Formula: | C54 H77 N9 O12 | | Definition date: | 2019-06-04 | | Last modified: | 2019-06-04 |
|
 | | PRD_002311 | | Name: | ACE-MVA-MP8-NZC-LEU-MP8-LEU-MVA-PRO-MLU-GLY | | Formula: | C57 H96 N10 O12 | | Definition date: | 2019-05-29 | | Last modified: | 2019-05-29 |
|
 | | PRD_002312 | | Name: | (GZJ)VDINNN(CY3) Cyclic peptide inhibitor | | Formula: | C36 H58 N12 O14 S | | Definition date: | 2019-04-17 | | Last modified: | 2019-04-17 |
|
 | | PRD_002313 | | Name: | WDINNN(BAL) Cyclic peptide inhibitor | | Formula: | C36 H49 N11 O12 | | Definition date: | 2019-04-17 | | Last modified: | 2019-04-17 |
|
